- Posts:
- 0 (0 per day)
- Age:
- N/A
- Date Registered:
- 2025-06-30, 23:28:01
- Local Time:
- 2025-07-02, 22:37:34
- Last Active:
- Yesterday at 01:53:40
Signature:
Background Despite remarkable success of immunotherapies with checkpoint blockade antibodies targeting programmed cell death protein 1 (PD-1), the maj